At busy Visp site, Lon­za will up mi­cro­bial ser­vices by 50%

In an ef­fort to up its de­vel­op­ment of mi­cro­bial-de­rived pro­teins, Swiss CD­MO Lon­za will in­vest in its man­u­fac­tur­ing ca­pac­i­ties in its home coun­try.

The ex­ten­sion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER